RecruitingNot Applicable

Investigating the Efficacy of OMT to Recover Olfactory Perception After COVID-19

United States32 participantsStarted 2024-08-29

Plain-language summary

One of the most widespread symptoms of COVID-19 is loss of the sense of smell. There are very few treatments for helping individuals recover their sense of smell. Osteopathic manipulative treatment (OMT) may be a useful tool in helping people recover their smell perception. In this study the investigators test whether OMT can be used to help individuals recover their sense of smell if they lost it during COVID-19.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Positive COVID-19 test or diagnoses * Self-reported deficiency in sense of smell Exclusion Criteria: * Age under 18 years * Pregnancy * Any findings on the osteopathic screening/evaluation that would hinder the effectiveness or increase the risk associated with OA decompression * Any medication that interferes with the sense of smell (intranasal zinc, intranasal antihistamines, intranasal corticosteroids) * Allergic rhinitis * Use of oral corticosteroids or antihistamines.

What they're measuring

Ability to Recover Sense of Smell after OMT

Timeframe: from enrollment until 2 weeks post treatment

Trial details

NCT IDNCT06766279

SponsorBurrell College of Osteopathic Medicine

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08

Contact for this trial

Thomas P Eiting, Ph.D

575-674-2245 teiting@burrell.edu

View on ClinicalTrials.gov More Anosmia trials